VEGFA and cancer: Unfortunately, hope for a “pan-cancer” anti-angiogenic therapy[2] had been greatly diminished with the finding that the efficacy of vascular endothelial growth factor (VEGF) signaling pathway inhibitors is modest and is restricted to certain advanced-stage cancers only.